04.23.24 -- Inside Tenaya Therapeutics' AAV9-Based Gene Therapy

This invaluable resource offers a gateway to the latest in precision medicine, clinical trials, and the transformative potential of targeted therapies in oncology.

It's important to frequently evaluate your manufacturing process, gauging if improvements can be made. Learn how aseptic connections can impact your efficiency and speed as you continue to scale-up.

Evaluate the performance of a single-use two-step plasmid purification process and see how it compares to the existing three-step purification method.

Discover how conducting a power analysis can determine the correct sample size for a statistically powered clone screening experiment.

Explore how filtration manufacturers optimize materials for performance and integration within single-use systems, including the value of optimizing sterile filtration and maximizing performance.

Cell health and quality are key determinants of the safety and efficacy of cell therapy. Review this portfolio of necessary controls that can increase accuracy by removing dead cells.

The choice of AAV analysis method depends on several factors. Here, we prove that mass photometry is a favorable method due to its accuracy, versatility, and low time, sample, and expertise requirements.

Examine how years of experience bolstered by continuous improvement efforts, enable hybrid clinical trial execution, from in-home clinical visits to site networks and digital platforms and technology.

Find out the steps teams can take to optimize reliably control environmental factors related to glucose, lactate, and pH using an HFB system during automated expansions of HEK293T cells.